SIRIO(SZ:300791) Zhong Guo Jing Ji Wang·2026-02-25 01:32Core Viewpoint - Xianle Health (300791.SZ) is expected to see a significant decline in net profit for the year 2025, with projections indicating a decrease of 53% to 69% compared to the previous year [1] Group 1: Financial Performance - The projected net profit attributable to shareholders for 2025 is estimated to be between 101.24 million yuan and 151.36 million yuan [1] - The net profit after deducting non-recurring gains and losses is expected to range from 57.50 million yuan to 85.97 million yuan, reflecting a decline of 74% to 82% year-on-year [1] Group 2: Fundraising Activities - Xianle Health raised a total of 1.09 billion yuan through the issuance of new shares in 2019, with a net amount of approximately 1.02 billion yuan after expenses [2] - The funds raised were allocated to various projects, including the construction of a production base in Ma'anshan, a research and development center, and a B2B marketing project [2] - The total amount raised from two fundraising activities is approximately 2.12 billion yuan [3]